Navigation Links
Ohio State receives $34M NIH grant

COLUMBUS, Ohio Medical researchers at The Ohio State University, in partnership with Nationwide Children's Hospital, have received a $34 million grant from the National Institutes of Health to create a center to develop clinical and translational protocols that help identify and advance treatments for patients. The grant is one of the largest ever received by Ohio State.

The Ohio State University Center for Clinical and Translational Science will provide support services to Ohio State researchers while fostering collaboration with other medical centers that are grant recipients.

"By facilitating collaborations among university medical centers, this NIH grant assures swift and meaningful advances in patient care," said Ohio State University President E. Gordon Gee. "The approach will accelerate research outcomes at Ohio State and elsewhere, and I am delighted that we are a part of this consortium."

Under the direction of Dr. Rebecca Jackson, professor of internal medicine, an endocrinologist and associate dean for clinical research, the center will leverage expertise from 16 colleges at Ohio State, along with scientists and clinicians at The Ohio State University Medical Center and Nationwide Children's Hospital.

The grant award provides administrative support needed to develop improved methods for analyzing research data and managing clinical trials, allowing for greater community outreach, and creating partnerships in central Ohio and beyond.

"With this award, we are joining a consortium of elite medical centers in developing innovative methods and approaches to research that bring proven treatments more quickly to patients," said Dr. Wiley "Chip" Souba Jr., dean of Ohio State's College of Medicine and interim senior vice president and executive dean for Health Sciences and CEO of the Medical Center. "This award speaks to the quality of our research, training programs, interdisciplinary collaboration, and partnerships with public and private organizations."

By engaging faculty and staff from across Ohio State, the center is creating a collaborative network focusing on science, education, research design and implementation. Additional emphasis is being placed on training the next generation of researchers by utilizing innovative educational initiatives to build their clinical and translational skills, while supporting their career development.

"The opportunities provided by the CTSA are enormously exciting for Ohio State investigators as well as the community," said Jackson. "This grant allows us to develop and refine educational and research approaches in clinical and translational science to enhance the rapid translation of new information to improve human health."

Ohio State is one of 30 medical centers across the country receiving the NIH grant targeted to strengthening clinical and translational science that will lead to better patient care. Administered by the National Center for Research Resources, a component of the NIH, the Clinical and Translational Science Award program funds diverse and far-reaching approaches related to all aspects of research.


Contact: Doug Flowers
Ohio State University Medical Center

Related medicine news :

1. Minnesota, National Long Term Care Advocates: Pending Bush Medicare Cut Hurts States Rural Seniors
2. IDC awarded Indias largest state government contract for digital radiography systems
3. NIH awards $25M clinical research grant to Indiana U for statewide initiative
4. PA State Health Officials Encourage Smokers to Quit on World No Tobacco Day
5. Type of Tomato Product Determines Power Against Prostate Cancer
6. Dehydrated tomatoes show promise for preventing prostate cancer
7. States Scorecard Finds Big Differences in Kids Health Care
8. No association found between vitamin D concentration in blood and risk of prostate cancer
9. Vitamin D Status Not Associated With Lower Prostate Risk
10. Pennsylvania Attorney General Corbett Announces Multi-State Settlement With Express Scripts Inc.
11. Monitoring blood flow helps improve prostate biopsies, Jefferson researchers report
Post Your Comments:
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
(Date:6/24/2016)... 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... inhaled drugs, announced today that it was added to ... its comprehensive set of U.S. and global equity ... an important milestone for Pulmatrix," said Chief Executive Officer ... of our progress in developing drugs for crucial unmet ...
Breaking Medicine Technology: